000 01341 a2200409 4500
005 20250516013439.0
264 0 _c20111020
008 201110s 0 0 eng d
022 _a1464-410X
024 7 _a10.1111/j.1464-410X.2010.09882.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSwinburn, Paul
245 0 0 _aPreferences for antimuscarinic therapy for overactive bladder.
_h[electronic resource]
260 _bBJU international
_cSep 2011
300 _a868-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscarinic Antagonists
_xtherapeutic use
650 0 4 _aPatient Preference
650 0 4 _aPilot Projects
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aUrinary Bladder, Overactive
_xdrug therapy
650 0 4 _aUrinary Incontinence
_xpsychology
700 1 _aLloyd, Andrew
700 1 _aAli, Shehzad
700 1 _aHashmi, Noreen
700 1 _aNewal, David
700 1 _aNajib, Hiba
773 0 _tBJU international
_gvol. 108
_gno. 6
_gp. 868-73
856 4 0 _uhttps://doi.org/10.1111/j.1464-410X.2010.09882.x
_zAvailable from publisher's website
999 _c20399156
_d20399156